4th Annual Oncology Market Access Summit

The World Congress 4th Annual Oncology Market Access Summit

UNPARALLELED OPPORTUNITY TO DISCUSS AND NETWORK WITH LEADING PAYERS, PROVIDERS AND PHARMACEUTICAL EXECUTIVES:

Strategize with Leading Pharmaceutical Executives:

Chris Mancill
Vice President, Government Programs and Reimbursement
EMD SERONO

Sue Naeyaert
Global Head, Pricing, Market Access and Policy, Biosimilars
Merck KGaA DARMSTADT, GERMANY

Lisa Samerdyke
Senior National Market Manager, Lilly Oncology
Eli Lilly

Gain Insight from Industry Payers and PBMs:

Matthew Farber
Senior Director, Oncology Disease State
Walgreen Co.

Brandon Hunter
Manager, Care Redesign
Blue Cross and Blue Shield of North Carolina

Bill Martin
Vice President and General Manager
Accredo - Express
Scripts

Marc Richmond, MD, MMM
Regional Medical Director Clinical Quality Network and Markets Support (CQNMS)
Blue Shield of California

Discuss Value-Based Healthcare with Providers:

Carmen Castillo, RN, CCM
Bone Marrow Transplant Service
Memorial Sloan Kettering Cancer Center

Karen K. Fields, MD
Senior Member Medical Oncology, Medical Director, Strategic Alliances
Moffitt Cancer Center

Oncology continues to be one of the fastest growing markets for the bio/pharmaceutical industry. With the implementation of CMS’s Oncology Care Model and similar models, value-based health care reform, multiple treatment pathways, and increased scrutiny over drug pricing and access, manufacturers face a variety of challenges in the increasingly competitive oncology space.

Now in its 4th year, the Oncology Market Access Summit brings together multiple stakeholder perspectives from Manufacturers, Payers, PBMs, Providers, and Cancer Organizations to share strategies that ensure market success in today’s complex health care ecosystem.

Join World Congress March 13- 14 in Philadelphia to participate in a multi-stakeholder discussion to find strategies that respond to these complex care, payment, and access challenges.

Top Reasons to Attend:

EXAMINE the manufacturer’s role in the utilization of CMS’ Oncology Care Model
COMPARE value frameworks from both the U.S. and abroad
GAIN Payer and PBM viewpoints around coverage and reimbursement
EXPLORE value-based contracting and MACRA implications to ensure market access success
LEARN Provider viewpoints around evidence-based information for successful collaboration
HEAR forward-thinking strategies when working with immuno-oncology, clinical pathways, ACOs, and advocacy partnerships

Testimonials

“Good mix of speakers. Good overview of cancer market access. Topics covered variety of areas for discussions.”

—Sahara Joish, Consultant, Kantar Health

Call for Papers: Submit Abstracts for Presentations

The World Congress Summit 4th Annual on Oncology Market Access Under New Payment and Delivery Models is now accepting abstract submissions for 2016! The deadline is September 30^th, 2016. Click here for details.

Associate Sponsors

Partners